Skip to main content

Contract Management: DOD's Anthrax Vaccine Manufacturer Will Continue to Need Financial Assistance

T-NSIAD-00-140 Published: Apr 14, 2000. Publicly Released: Apr 14, 2000.
Jump To:
Skip to Highlights


Pursuant to a congressional request, GAO discussed the contractual relationship between the Department of Defense (DOD) and BioPort Corporation for production of the anthrax vaccine, focusing on: (1) the financial assistance DOD provided BioPort in 1999; and (2) additional financial assistance DOD is providing BioPort in 2000.

Full Report

Office of Public Affairs


Advance paymentsBiological warfareChemical agentsBiological agentsAnthraxContract modificationsContract performanceContract termsDefense procurementDepartment of Defense contractorsFinancial analysisImmunization programsImmunization services